Slingshot members are tracking this corporate initiative:
Teva (TEVA) and Regeneron (REGN) Agree to Global Commercialization and Development Deal for REGN's Fasinumab in Chronic Lower Back Pain
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Sep 20, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords Global Partnership, Commercialization, Development, Fasinumab, Chronic Lower Back Pain